Earnings History Data for Organon & Co. (OGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Organon & Co.

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	PM		OGN	Organon & Co.	4,600	0.81	0.79	0.78	Organon Non-GAAP EPS of $0.87 misses by $0.03, revenue of $1.58B beats by $20M [10/31/2024 7:32 AM]	18.75	0.82 (4.57%)	18.01	0.08 (0.45%)	10.84 - 23.10	3,537,984	2,000,000	8,987
Organon Q3 2024 Earnings Preview: Dermavant purchase in focus [10/30/2024 2:44 PM] FDA accepts Organon BLA for Prolia/Xgeva biosimilar [10/30/2024 12:39 PM] Organon Non-GAAP EPS of $0.87 misses by $0.03, revenue of $1.58B beats by $20M [10/31/2024 7:32 AM] Organon in charts: Revenue from Europe and Canada rises most among geographies in Q3 [10/31/2024 9:02 AM] Organon declares $0.28 dividend [10/31/2024 10:34 AM] Organon Reports Results for the Third Quarter Ended September30, 2024 [2024-10-31 07:30AM] Shanghai Henlius Biotech, Organon announce FDA acceptance of BLA for HLX14 [2024-10-31 04:43AM] US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab) [Oct-30-24 06:00AM]
06-08-2024	PM		OGN	Organon & Co.	5,570	1.03	1.01	1.31	Organon Non-GAAP EPS of $1.12 beats by $0.04, revenue of $1.61B misses by $10M [8/6/2024 7:31 AM]	18.65	-1.54 (-7.63%)	18.65	0.0 (0.00%)	10.84 - 24.08	8,370,460	1,680,000	555
Organon Non-GAAP EPS of $1.12 beats by $0.04, revenue of $1.61B misses by $10M [8/6/2024 7:31 AM] Organon & Co in charts: Biosimilars revenue jumps 22% Y/Y in Q2, down sequentially [8/6/2024 7:59 AM] Earnings summary: Organon & Co reports mixed Q2 results; narrows FY24 revenue outlook [8/6/2024 8:19 AM] Organon declares $0.28 dividend [8/6/2024 9:11 AM] Organon extends selloff after Q2 results [8/6/2024 2:27 PM]
02-05-2024	PM		OGN	Organon & Co.	4,830	1.14	0.83	1.08	Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue of $1.62B beats by $60M [5/2/2024 7:32 AM]	19.57	0.74 (3.93%)	19.40	0.57 (3.03%)	10.84 - 24.58	4,054,604	2,150,000	13,964
Organon declares $0.28 dividend [5/2/2024 9:37 AM] Organon in charts: Strong Q1 with Women's Health up 11% and Biosimilars soaring 47% Y/Y [5/2/2024 8:11 AM] Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue of $1.62B beats by $60M [5/2/2024 7:32 AM] Organon Q1 2024 Earnings Preview [5/1/2024 11:26 AM]
15-02-2024	PM		OGN	Organon & Co.	4,120	0.87	0.73	0.81	Organon beats top-line and bottom-line estimates; initiates FY24 outlook [2/15/2024 7:32 AM]	18.63	2.27 (13.88%)	17.61	1.25 (7.64%)	10.84 - 29.36	6,805,827	2,500,000	47,740
Organon gaining momentum ahead of Q4 earnings [2/14/2024 12:33 PM] Organon beats top-line and bottom-line estimates; initiates FY24 outlook [2/15/2024 7:32 AM] Organon in charts: Biosimilars revenue rises by ~49% and Women’s Health revenue by 7% in Q4 [2/15/2024 7:50 AM] Organon declares $0.28 dividend [2/15/2024 9:20 AM] Organon nears five-month high after Q4 beat [2/15/2024 11:33 AM]
02-11-2023	PM		OGN	Organon & Co.	3,780	0.78	1.04	1.32	Organon Non-GAAP EPS of $0.87 misses by $0.19, revenue of $1.52B misses by $50M [11/2/2023 7:31 AM]	13.11	-1.54 (-10.51%)	13.11	0.0 (0.00%)	12.65 - 32.43	11,298,966	3,330,000	7,247
Organon Q3 2023 Earnings Preview [11/1/2023 12:56 PM] Organon Non-GAAP EPS of $0.87 misses by $0.19, revenue of $1.52B misses by $50M [11/2/2023 7:31 AM] Organon declares $0.28 dividend [11/2/2023 10:26 AM] Organon stock plumbs all-time low on Q3 weakness in flagship women's health unit [11/2/2023 1:29 PM]
08-08-2023	PM		OGN	Organon & Co.	5,490	1.31	0.97	1.25	Organon Non-GAAP EPS of $1.31, revenue of $1.61B [8/8/2023 7:34 AM]	23.73	1.93 (8.85%)	22.10	0.30 (1.38%)	18.87 - 32.43	5,432,752	2,520,000	5,056
Organon Non-GAAP EPS of $1.31, revenue of $1.61B [8/8/2023 7:34 AM] Organon jumps ~9% on strong Q2 driven by higher contraceptive sales, growth in biosimilars [8/8/2023 2:47 PM]
04-05-2023	PM	7:30 AM ET (May 4)	OGN	Organon & Co.	6,120	1.08	1.18	1.65	Organon Non-GAAP EPS of $1.08 misses by $0.08, revenue of $1.54B in-line [5/4/2023 7:31 AM]	22.02	-2.22 (-9.18%)	23.52	-0.72 (-2.97%)	20.96 - 39.09	3,352,221	1,520,000	1,080
Organon Q1 2023 earnings on deck, what to expect [5/3/2023 2:25 PM] Organon Non-GAAP EPS of $1.08 misses by $0.08, revenue of $1.54B in-line [5/4/2023 7:31 AM] Organon declares $0.28 dividend [5/4/2023 10:21 AM] Organon stock slumps ~10% as Q1 profit contracts amid flat revenue [5/4/2023 12:05 PM]
16-02-2023	PM	7:30 AM ET (Feb 16)	OGN	Organon & Co.	7,410	0.81	0.85	1.37	Organon Non-GAAP EPS of $0.81 misses by $0.10, revenue of $1.49B misses by $10M [2/16/2023 7:31 AM]	24.86	-4.41 (-15.05%)	27.87	-1.39 (-4.75%)	22.88 - 39.47	8,713,157	1,250,000	17,601
What to expect from Organon Q4 earnings [2/15/2023 10:53 AM] Organon Non-GAAP EPS of $0.81 misses by $0.10, revenue of $1.49B misses by $10M [2/16/2023 7:31 AM] Organon trades lower after Q4 miss, uptick in Women's Health but Established Brands revenue dips [2/16/2023 9:24 AM]
03-11-2022	PM	7:30 AM ET (Nov 3)	OGN	Organon & Co.	6,710	1.32	1.12	1.67	Organon Non-GAAP EPS of $1.32 beats by $0.22, revenue of $1.54B beats by $20M [11/3/2022 7:31 AM]	25.84	-0.09 (-0.37%)	27.40	1.47 (5.67%)	22.88 - 39.48	2,619,780	1,860,000	2,237
Organon Non-GAAP EPS of $1.32 beats by $0.22, revenue of $1.54B beats by $20M [11/3/2022 7:31 AM] Organon gains after earnings beat despite contraction in topline [11/3/2022 10:19 AM] Organon Reports Results for the Third Quarter Ended September 30, 2022 [Nov-03-22 07:30AM]
04-08-2022	PM	7:30 AM ET (Aug 4)	OGN	Organon & Co.	8,110	1.25	1.16	1.72	Organon Non-GAAP EPS of $1.25 beats by $0.06, revenue of $1.59B beats by $60M, lowers FY22 mid-point revenue guidance [8/4/2022 7:32 AM]	32.44	-0.13 (-0.41%)	32.60	0.03 (0.09%)	28.50 - 39.48	1,887,820	1,460,000	1,260
Organon Q2 2022 Earnings Preview [8/3/2022 10:12 AM] Organon Non-GAAP EPS of $1.25 beats by $0.06, revenue of $1.59B beats by $60M, lowers FY22 mid-point revenue guidance [8/4/2022 7:32 AM] Organon tightens 2022 revenue guidance on forex headwinds [8/4/2022 10:30 AM]
05-05-2022	PM	6:30 AM ET (May 5)	OGN	Organon & Co.	8,140	1.65	1.31	1.56	Organon Non-GAAP EPS of $1.65 beats by $0.35, revenue of $1.57B beats by $50M [5/5/2022 7:31 AM]	34.88	1.69 (5.08%)	32.93	-0.26 (-0.78%)	27.25 - 39.48	3,123,044	1,610,000	7,409
Organon Q1 2022 Earnings Preview [5/4/2022 10:19 AM] Organon Non-GAAP EPS of $1.65 beats by $0.35, revenue of $1.57B beats by $50M [5/5/2022 7:31 AM] Organon posts Q1 beat as topline growth returns thanks to established brands [5/5/2022 8:44 AM] Organon declares $0.28 dividend [5/5/2022 9:29 AM] Organon Reports Results for the First Quarter Ended March 31, 2022 [May-05-22 07:30AM]
17-02-2022	PM	6:30 AM ET (Feb 17)	OGN	Organon & Co.	8,720	1.37	1.25	0.00	Organon Non-GAAP EPS of $1.37 beats by $0.10, revenue of $1.6B beats by $20M [2/17/2022 6:31 AM]	36.35	0.01 (0.03%)	35.25	-1.09 (-3.00%)	27.25 - 38.75	4,256,558	1,720,000	30,161
Will Organon Q4 earnings bring positive surprise? [2/16/2022 11:04 AM] Organon acquires rights for oral contraceptive pills in China from Bayer [2/16/2022 8:55 AM] Organon Non-GAAP EPS of $1.37 beats by $0.10, revenue of $1.6B beats by $20M [2/17/2022 6:31 AM] Organon projects in-line guidance for 2022 as topline and bottom-line contract [2/17/2022 7:28 AM] Organon declares $0.28 dividend [2/17/2022 7:38 AM] Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the Peoples Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam [Feb-16-22 08:30AM] Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021 [Feb-17-22 06:30AM]
11-11-2021	PM	7:00 AM ET (Nov 11)	OGN	Organon & Co.	9,290	1.67	1.44	0.00	Organon EPS beats by $0.23, beats on revenue [11/11/2021 6:44 AM]	34.72	-1.91 (-5.23%)	35.38	-1.25 (-3.41%)	27.25 - 38.75	5,578,778	2,130,000	12,040
Organon Q3 2021 Earnings Preview [11/10/2021 12:11 PM] Organon EPS beats by $0.23, beats on revenue [11/11/2021 6:44 AM] Organon declares $0.28 dividend [11/11/2021 7:02 AM] Organon narrows 2021 guidance; agrees to acquire Forendo Pharma for $954M [11/11/2021 7:10 AM] Organon to Acquire Forendo Pharma [Nov-11-21 06:30AM] Organon Reports Results for the Third Quarter Ended September 30, 2021 [Nov-11-21 06:31AM]
12-08-2021	PM	8:30 AM ET (Aug 12)	OGN	Organon & Co.	7,690	1.72	1.49	0.00	Organon EPS beats by $0.29, beats on revenue [8/12/2021 7:16 AM]	33.48	3.55 (11.86%)	31.07	1.14 (3.81%)	27.25 - 38.75	7,399,467	1,860,000	68,297
Organon Q2 2021 Earnings Preview [8/11/2021 2:56 PM] Organon EPS beats by $0.29, beats on revenue [8/12/2021 7:16 AM] Organon declares $0.28 dividend [8/12/2021 7:20 AM] Organon posts quarterly revenue growth driven by Women’s Health [8/12/2021 7:57 AM] Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend [Aug-12-21 07:00AM]